89
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Substance use and perceived barriers to antiretroviral therapy adherence among people living with HIV in Guangxi, China

, , , , &
Pages 314-321 | Received 11 Mar 2018, Accepted 23 Aug 2018, Published online: 03 Dec 2018

References

  • Amico K, Toro-Alfonso J, Fisher JD. 2005. An empirical test of the information, motivation and behavioral skills model of antiretroviral therapy adherence. AIDS Care. 17:661–673.
  • Antiretroviral Therapy Cohort Collaboration. 2017. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 4:e349–e356.
  • Arnsten JH, Li X, Mizuno Y, Knowlton AR, Gourevitch MN, Handley K, Knight KR, Metsch LR; INSPIRE Study Team. 2007. Factors associated with antiretroviral therapy adherence and medication errors among HIV-infected injection drug users. J Acquir Immune Defic Syndr. 46:S64–S71.
  • Baum MK, Rafie C, Lai S, Sales S, Page JB, Campa A. 2010. Alcohol use accelerates HIV disease progression. AIDS Res Hum Retroviruses. 26:511–518.
  • Carrieri MP, Protopopescu C, Raffi F, March L, Reboud P, Spire B, Leport C; the ANRS CO8 APROCO-COPILOTE Study Group. 2014. Low alcohol consumption as a predictor of higher CD4+ cell count in HIV-treated patients: A French paradox or a proxy of healthy behaviors? The ANRS APROCO-COPILOTE CO-08 cohort. J Acquir Immune Defic Syndr. 65:e148–e50.
  • Chinanews. 2017. In China 60% of the people living with HIV/AIDS have received antiretroviral therapy. [cited 2018 July 2]. http://www.chinanews.com/sh/2017/09-27/8341579.shtml
  • Cooper V, Gellaitry G, Hankins M, Fisher M, Horne R. 2009. The influence of symptom experiences and attributions on adherence to highly active anti-retroviral therapy (HAART): A six-month prospective, follow-up study. AIDS Care. 21:520–528.
  • Do HM, Dunne MP, Kato M, Pham CV, Nguyen KV. 2013. Factors associated with suboptimal adherence to antiretroviral therapy in Viet Nam: a cross-sectional study using audio computer-assisted self-interview (ACASI). BMC Infect Dis. 13:154.
  • Fama R, Sullivan EV, Sassoon SA, Pfefferbaum A, Zahr NM. 2016. Impairments in component processes of executive function and episodic memory in alcoholism, HIV infection, and HIV infection with alcoholism comorbidity. Alcohol Clin Exp Res. 40:2656–2666.
  • Gonzalez A, Barinas J, O’Cleirigh C. 2011. Substance use: Impact on adherence and HIV medical treatment. Curr HIV/AIDS Rep. 8:223–234.
  • Grau LE, Griffiths-Kundishora A, Heimer R, Hutcheson M, Nunn A, Towey C, Stopka TJ. 2017. Barriers and facilitators of the HIV care continuum in Southern New England for people with drug or alcohol use and living with HIV/AIDS: perspectives of HIV surveillance experts and service providers. Addict Sci Clin Prac. 12:24.
  • Ickovics JR, Meisler AW. 1997. Adherence in AIDS clinical trials: A framework for clinical research and clinical care. J Clin Epidemiol. 50:385–391.
  • Kader R, Seedat S, Govender R, Koch JR, Parry CD. 2014. Hazardous and Harmful use of alcohol and/or other drugs and health status among South African patients attending HIV clinics. AIDS & Behav. 18:525–534.
  • King RM, Vidrine DJ, Danysh HE, Fletcher FE, McCurdy S, Arduino RC, Gritz ER. 2012. Factors associated with nonadherence to antiretroviral therapy in HIV-positive smokers. AIDS Patient Care STDs. 26(8):479–485.
  • Krüsi A, Wood E, Montaner J, Kerr T. 2010. Social and structural determinants of HAART access and adherence among injection drug users. Int J Drug Pol. 21:4–9.
  • Lal V, Kant S, Dewan R, Rai SK. 2010. Reasons for non-adherence to antiretroviral therapy among adult patients receiving free treatment at a tertiary care hospital in Delhi. Ind J Commun Med. 35:172–173.
  • Langebeek N, Gisolf EH, Reiss P, Vervoort SC, Hafsteinsdóttir TB, Richter C, Sprangers MA, Nieuwkerk PT. 2014. Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Med. 12:142.
  • Lucas GM, Gebo KA, Chaisson RE, Moore RD. 2002. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS. 16:767–774.
  • Malta M, Strathdee SA, Magnanini MM, Bastos FI. 2008. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction. 103:1242–1257.
  • Meade CS, Drabkin AS, Hansen NB, Wilson PA, Kochman A, Sikkema KJ. 2010. Reductions in alcohol and cocaine use following a group coping intervention for HIV-positive adults with childhood sexual abuse histories. Addiction. 105:1942–1951.
  • Molina PE, Happel KI, Zang P, Kolls JK, Nelson S. 2010. Focus on: Alcohol and the immune system. Alcohol Res Health. 33:97–108.
  • Ortego C, Huedo-Medina TB, Llorca J, Sevilla L, Santos P, Rodrıguez E, Warren MR, Vejo J. 2011. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis. AIDS Behave. 15:1381–1396.
  • Outlaw A, Naar-King S, Green-Jones M, Wright K, Condon K, Sherry L, Janisse H. 2010. Predictors of optimal HIV appointment adherence in minority youth: a prospective study. J Pediatr Psychol. 35:1011–1015.
  • Peretti-Watel P, Spire B, Lert F, Obadia Y; VESPA Group. 2006. Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients. Drug Alcohol Depend. 82:S71–S79.
  • Reda AA, Biadgilign S. 2012. Determinants of adherence to antiretroviral therapy among HIV-infected patients in Africa. AIDS Res Treat. 2102:574656.
  • Rehm J, Samokhvalov AV, Neuman MG, Room R, Parry C, Lönnroth K, Patra J, Poznyak V, Popova, S. 2009. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Publ Health. 9:450.
  • Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A, Volsky DJ, McArthur JC. 2016 HIV-associated neurocognitive disorder – pathogenesis and prospects for treatment. Nat Rev Neurol. 12:234–248.
  • Thaler NS, Sayegh P, Kim MS, Castellon SA, Hinkin CH. 2015. Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease. Arch Clin Neuropsychol. 30:114–121.
  • Tsao JC, Dobalian A, Stein JA. 2005. Illness burden mediates the relationship between pain and illicit drug use in persons living with HIV. Pain. 9(1–3):124–132.
  • Tucker JS, Orlando M, Burnam MA, Sherbourne CD, Kung FY, Gifford AL. 2004. Psychosocial mediators of antiretroviral non-adherence in HIV-positive adults with substance use and mental health problems. Health Psychol. 23:363–370.
  • UNAIDS. 2014. 90-90-90: An ambitious treatment target to help end the AIDS epidemic. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS.
  • Vagenas P, Azar MM, Copenhaver MM, Springer SA, Molina PE, Altice FL. 2015. The impact of alcohol use and related disorders on the HIV continuum of care: A systematic review. Curr HIV/AIDS Rep. 12:421–436.
  • Wasti SP, van Teijlingen E, Simkhada P, Randall J, Baxter S, Kirkpatrick P, GC VS. 2012. Factors influencing adherence to antiretroviral treatment in Asian developing countries: a systematic review. Trop Med Int Health. 17:71–81.
  • Xinhuanet. 2017. Experts: Expanding the testing to prevent HIV transmission. [cited 2018 July 2] http://www.china-efe.org/efe/jk/yy/20170831/164491.html
  • Zhou G, Li X, Qiao S, Zhou Y, Shen Z. 2017. Psychological and behavioral barriers to ART adherence among PLWH in China: role of self efficacy. AIDS Care. 29:1533–1537.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.